8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2018 / Controlled trial
Fifteen healthy females were evaluated for mood, cognition, and whole-brain MR spectroscopic imaging before and after 72 hours of fasting, and compared with 15 age-matched non-fasting females. After fasting, mood scores significantly increased. Glx decreased across all nine brain regions examined, tCho decreased in eight, NAA in four, and tCr in one, with Glx showing the greatest change and the frontal lobes being the most affected brain region.
Ding XQ, Maudsley AA, Schweiger U, et al. J Cereb Blood Flow Metab, 2018. PMID 28273723
2018 / Randomized controlled trial
In a randomized controlled trial of 37 adults aged 60 to 75 years, consuming 24 g/day of freeze-dried blueberry for 90 days improved executive function markers compared to placebo. Participants receiving blueberry showed fewer verbal learning repetition errors (p = 0.031) and reduced switch cost on task switching (p = 0.033). However, the intervention produced no changes in gait or balance performance.
Miller MG, Hamilton DA, Joseph JA, et al. Eur J Nutr, 2018. PMID 28283823
2018 / Double-blind randomized controlled trial
A double-blind clinical trial evaluated the effect of vitamin D supplementation on sleep in 89 participants aged 20-50 years with sleep disorders (44 in the intervention group and 45 in the placebo group). The intervention group received a 50,000-unit vitamin D supplement once every two weeks for 8 weeks, while the control group received a placebo. At the end of the study, the sleep score (PSQI) was significantly reduced in vitamin D recipients compared with placebo recipients (P < 0.05), even after adjusting for confounding variables (P < 0.05).
Majid MS, Ahmad HS, Bizhan H, et al. Nutr Neurosci, 2018. PMID 28475473
2018 / Randomized controlled trial
Sixty patients with tension-type headache were randomized to 10 weeks of strength training with elastic resistance bands or a control group receiving ergonomic and posture correction, with follow-up at 19-22 weeks. No between-group effect was detected. Within groups, the strength training group saw headache frequency decrease by 11% (P = 0.041) and duration by 10% (P = 0.036), while the control group showed reductions of 24% (P = 0.0033) and 27% (P = 0.041), respectively. The authors concluded that within-group effects did not reach clinical significance.
Madsen BK, Søgaard K, Andersen LL, et al. Cephalalgia, 2018. PMID 28750588
2018 / Randomized crossover trial
Eleven overweight young women completed 2 days of zero-calorie fasting and 2 days of their usual diet in random order. Fasting decreased log-transformed high-frequency power, indicating higher sympathetic activity, without altering heart rate. Fasting did not change mood, prefrontal cortex activity, or cognitive, motor, or psychomotor performance.
Solianik R, Sujeta A Behav Brain Res, 2018. PMID 29097329
2018 / Double-blind, placebo-controlled randomized trial
Forty non-demented adults aged 51-84 were randomized to receive 90 mg curcumin twice daily as Theracurmin (N=21) or placebo (N=19) for 18 months. Curcumin improved verbal memory (SRT Consistent Long-Term Retrieval: ES=0.63, p=0.002; between-group ES=0.68, p=0.05), visual memory (BVMT-R Recall: ES=0.50, p=0.01; BVMT-R Delay: ES=0.51, p=0.006), and attention (ES=0.96, p<0.0001; between-group ES=0.67, p=0.04). FDDNP-PET binding decreased in the amygdala with curcumin (ES=-0.41, p=0.04; between-group ES=0.48, p=0.07) and remained unchanged in the hypothalamus with curcumin while increasing with placebo (between-group ES=0.55, p=0.02).
Small GW, Siddarth P, Li Z, et al. Am J Geriatr Psychiatry, 2018. PMID 29246725
2018 / 16-week randomized crossover noninferiority pilot study
Fourteen Parkinson's disease patients with motor fluctuations and dyskinesias received Mucuna pruriens (MP) powder and levodopa/carbidopa (LD/CD) in a randomized crossover design over 16 weeks. Seven patients (50%) discontinued MP prematurely due to gastrointestinal side effects (n=4) or progressive worsening of motor performance (n=3), whereas no patients discontinued during the LD/CD phase. In patients who tolerated MP, the clinical response was similar to LD/CD across all efficacy outcomes. Dropouts later tolerated an MP supernatant water formulation in a study extension (median 16 weeks).
Cilia R, Laguna J, Cassani E, et al. Parkinsonism Relat Disord, 2018. PMID 29352722
2018 / Interventional crossover study
PET and 18F-florbetaben were used to measure brain β-amyloid burden (ABB) in 20 healthy controls after a night of rested sleep and after a night of sleep deprivation. One night of sleep deprivation significantly increased ABB in the right hippocampus and thalamus compared with baseline. These increases correlated with mood worsening after sleep deprivation but were not related to APOE genotype. Baseline ABB across subcortical regions and the precuneus was inversely associated with reported night sleep hours.
Shokri-Kojori E, Wang GJ, Wiers CE, et al. Proc Natl Acad Sci U S A, 2018. PMID 29632177
2018 / Multicentre pragmatic randomized controlled trial
A pragmatic randomized trial assigned 494 people with dementia to four months of supervised aerobic and strength exercise plus usual care (n=329) or usual care alone (n=165). At 12 months, the mean ADAS-cog score was 25.2 in the exercise group versus 23.8 in usual care (adjusted difference -1.4, 95% CI -2.6 to -0.2, P=0.03), indicating greater cognitive impairment in the exercise arm, though the clinical relevance is uncertain. No differences were detected in secondary outcomes, including activities of daily living, neuropsychiatric symptoms, or quality of life, despite improved six-minute walking distance in the exercise group (mean change 18.1 m, 95% CI 11.6 to 24.6 m).
Lamb SE, Sheehan B, Atherton N, et al. BMJ, 2018. PMID 29769247
2018 / Crossover trial
Fifteen healthy young men completed 30 minutes of cycle ergometer exercise at 60% of VO2 peak with either self-selected music or no music. Rate of perceived exertion right before completing exercise was significantly lower in the music condition compared to the non-music condition. Inhibitory control measured via the Stroop task significantly improved immediately after exercise and during the 30-minute recovery period in both conditions, with no significant difference between the music and non-music conditions.
Tanaka D, Tsukamoto H, Suga T, et al. Physiol Behav, 2018. PMID 29807054
2018 / Randomized crossover trial
Nine obese women aged 22-31 years were tested under two randomly allocated conditions: a 2-day very low-calorie diet (511 kcal) and a 2-day usual diet. The calorie-restricted diet received a subjective stress rating of 41.5 ± 23.3, but had no detectable effects on heart rate variability indices, mood, grip strength, or psychomotor functions. However, calorie restriction significantly increased spatial processing and visuospatial working memory accuracy (p < 0.05) and decreased cognitive flexibility accuracy (p < 0.05).
Solianik R, Sujeta A, Čekanauskaitė A Exp Brain Res, 2018. PMID 29860630
2018 / Prospective single-arm study
Twenty children with refractory epilepsy were prospectively evaluated before and 6 months after starting a ketogenic diet. Following 6 months of therapy, 2 patients became seizure-free, 3 achieved a ≥ 90% reduction, 5 had a 50-89% reduction, and 10 had a < 50% reduction, with all 10 responders showing EEG improvements. Fecal microbial profiles demonstrated lower alpha diversity compared with baseline, along with significantly decreased Firmicutes and increased Bacteroidetes abundance. Non-responsive patients were found to have enrichment of Clostridiales, Ruminococcaceae, Rikenellaceae, Lachnospiraceae, and Alistipes.
Zhang Y, Zhou S, Zhou Y, et al. Epilepsy Res, 2018. PMID 30007242
2018 / Randomized controlled trial
One hundred pregnant women with insomnia were randomized to receive 1,000 mg of lettuce seed capsules or a placebo daily for 2 weeks. Sleep quality improved significantly more in the lettuce seed group than in the placebo group as measured by the Pittsburgh Sleep Quality Index. After controlling for other variables, the experimental group had significantly lower average sleep scores (p = 0.03).
Pour ZS, Hosseinkhani A, Asadi N, et al. J Ethnopharmacol, 2018. PMID 30172900
2018 / Randomized, double-blind, placebo-controlled pilot trial
Thirty-nine participants with mild to moderate Alzheimer's disease were randomized to receive either an oral preparation containing 5 mg resveratrol, 5 g dextrose, and 5 g malate (RGM) or a matching placebo twice daily with grape juice for 1 year. At 12 months, change scores on the ADAS-cog, MMSE, ADCS-ADL, and NPI showed less deterioration in the treatment group than the control group, but none of these differences reached statistical significance. The intervention was found to be safe and well tolerated, with the most common adverse events being falls (all in the control group and deemed unrelated to the study).
Zhu CW, Grossman H, Neugroschl J, et al. Alzheimers Dement (N Y), 2018. PMID 30480082
2017 / Randomized controlled trial
In a double-blind pilot study, 10 older adults with mild cognitive decline received an active grape formulation or placebo for six months. Participants taking the grape formulation maintained cerebral metabolism on FDG-PET scans, whereas the placebo group experienced significant metabolic declines in posterior cingulate and temporal regions (p < 0.05). Neuropsychological test scores did not differ significantly between groups.
Lee J, Torosyan N, Silverman DH Exp Gerontol, 2017. PMID 27856335
2017 / Randomized placebo-controlled trial
Eighty post-menopausal women aged 45-85 years were randomized to take trans-resveratrol or placebo for 14 weeks. Compared to placebo, resveratrol led to 17% increases in cerebrovascular responsiveness (CVR) to both hypercapnic (p = 0.010) and cognitive stimuli (p = 0.002). Resveratrol significantly improved performance in verbal memory tasks (p = 0.041) and overall cognitive performance (p = 0.020), which correlated with the increase in CVR (r = 0.327; p = 0.048). Mood tended to improve across multiple measures, but the changes were not statistically significant.
Evans HM, Howe PR, Wong RH Nutrients, 2017. PMID 28054939
2017 / Randomized controlled trial (retrospective subset analysis)
Banked CSF and plasma samples from a subset of 38 biomarker-confirmed Alzheimer's disease subjects randomized to resveratrol (up to 1 g orally twice daily) or placebo for 52 weeks were analyzed. At 52 weeks, resveratrol significantly reduced CSF MMP9 and increased MDC, IL-4, and FGF-2 compared to placebo, while increasing plasma MMP10 and decreasing IL-12P40, IL12P70, and RANTES from baseline. Resveratrol treatment attenuated declines in MMSE scores, ADCS-ADL scores, and CSF Aβ42 levels over 52 weeks, without altering tau levels.
Moussa C, Hebron M, Huang X, et al. J Neuroinflammation, 2017. PMID 28086917
2017 / 12-week, parallel-group, single-blind randomized controlled trial
In the 'SMILES' trial, 67 adults with moderate to severe depression were randomized to receive either 7 sessions of dietary support from a clinical dietician (n=33) or a social support control protocol (n=34) over 12 weeks. The dietary support group showed significantly greater improvement on the MADRS compared with the control group (t(60.7) = 4.38, p < 0.001, Cohen's d = -1.16). Remission (MADRS <10) was achieved by 32.3% (n=10) of the intervention group compared to 8.0% (n=2) of controls (p = 0.028), with a number needed to treat of 4.1 (95% CI 2.3-27.8).
Jacka FN, O'Neil A, Opie R, et al. BMC Med, 2017. PMID 28137247
2017 / Randomized controlled trial
A 14-day randomized controlled trial assigned 171 low-fruit-and-vegetable-consuming young adults to a diet-as-usual control, an ecological momentary intervention (text reminders plus vouchers), or a fruit and vegetable intervention (FVI) providing two additional daily servings of fresh produce. Only participants in the FVI condition exhibited improvements in psychological well-being, showing increases in vitality, flourishing, and motivation relative to the other groups. No changes were observed for depressive symptoms, anxiety, or positive and negative mood. These benefits were not mediated by vitamin C, carotenoids, or psychological expectancies.
Conner TS, Brookie KL, Carr AC, et al. PLoS One, 2017. PMID 28158239
2017 / Controlled pharmacokinetic and pharmacodynamic trial
Healthy adults were administered cannabis brownies containing 10, 25, or 50 mg THC, with whole blood, oral fluid, and pharmacodynamic outcomes tracked over 9 days. Mean Cmax for THC in whole blood was 1, 3.5, and 3.3 ng/mL for the 10, 25, and 50 mg doses, with detection windows ranging from 0 to 22 h in blood and 1.9 to 22 h in oral fluid. Subjective drug and cognitive performance effects were generally dose dependent, peaked at 1.5–3 h post-administration, and lasted 6–8 h. Whole blood cannabinoid concentrations significantly correlated with subjective effects, but correlations with cognitive performance or between oral fluid and pharmacodynamic outcomes were non-significant or not orderly by dose.
Vandrey R, Herrmann ES, Mitchell JM, et al. J Anal Toxicol, 2017. PMID 28158482
2017 / Counterbalanced crossover trial and randomized controlled trial
Two double-blind studies examined mood 2 hours after blueberry or placebo drinks. Study 1 enrolled 21 young adults aged 18-21 in a counterbalanced crossover design, while Study 2 randomized 50 children aged 7-10. In both cohorts, consuming the flavonoid-rich blueberry beverage significantly boosted positive affect based on a significant drink-by-session interaction. Neither study detected any changes in negative affect.
Khalid S, Barfoot KL, May G, et al. Nutrients, 2017. PMID 28230732
2017 / Randomized controlled trial
Healthy older adults were randomized to consume 30 mL of anthocyanin-rich blueberry concentrate (12 participants) or isoenergetic placebo (14 participants) over 12 weeks. Blueberry supplementation led to significant increases in brain activity relative to placebo within multiple regions including Brodmann areas 4/6/10/21/40/44/45, precuneus, anterior cingulate, and insula/thalamus (p < 0.001). Significant improvements in grey matter perfusion were observed in parietal (5.0 ± 1.8 vs -2.9 ± 2.4%, p = 0.013) and occipital (8.0 ± 2.6 vs -0.7 ± 3.2%, p = 0.031) lobes, alongside evidence suggesting improvement in working memory (p = 0.05).
Bowtell JL, Aboo-Bakkar Z, Conway ME, et al. Appl Physiol Nutr Metab, 2017. PMID 28249119
2017 / Randomized clinical trial transformed into a cohort study
The PREADViSE trial evaluated whether vitamin E, selenium, or their combination could prevent dementia in asymptomatic older men, starting as a randomized clinical trial and continuing as a cohort study. Across 7338 analyzed men, dementia incidence was 4.4% (325 cases) and did not differ among the study arms. Adjusted hazard ratios compared with placebo were 0.88 (95% CI, 0.64-1.20) for vitamin E, 0.83 (95% CI, 0.60-1.13) for selenium, and 1.00 (95% CI, 0.75-1.35) for the combination.
Kryscio RJ, Abner EL, Caban-Holt A, et al. JAMA Neurol, 2017. PMID 28319243
2017 / Randomized controlled trial
Twenty-six older adults with a mean age of 65.4 years participated in a six-week randomized trial combining exercise with beet root juice or a placebo. The beet root juice group showed significantly higher somatomotor community structure consistency (P = 0.007) and fewer secondary connections to the insular cortex (P = 0.017). Peak exercise capacity also showed a nonsignificant trend toward improvement.
Petrie M, Rejeski WJ, Basu S, et al. J Gerontol A Biol Sci Med Sci, 2017. PMID 28329785